Advancing Healthcare with Prescription Digital Therapeutics

Mahsa Salsabili, PharmD, PhD, presents an overview of prescription digital therapeutics and their application in addressing unmet patient needs across various disease states, including diabetes, addiction, and mental health conditions.

A medical professional examines the potential for cost-effective frontline treatments and personalized care delivered through a mobile application at the patient's own pace, emphasizing the significance of high self-motivation and patient activation, while also discussing the role of prescription digital therapeutics in adjunct therapy.

A medical professional reviews the clinical application of prescription digital therapeutics in both monotherapy and adjunct therapy roles, emphasizing their potential for stand-alone treatment in substance abuse and other chronic illnesses, while also noting their complementary role in conjunction with other treatments as adjunct therapy.

Mahsa Salsabili, PharmD, PhD, underscores the potential cost-effectiveness of treatment through the adoption of prescription digital therapeutics, while acknowledging that additional evidence is required to conclusively determine their cost-effectiveness.

Mahsa Salsabili, PharmD, PhD, delves into the FDA approval process for prescription digital therapeutics , which requires market approval, clinical studies and real-world evidence, to establish their efficacy in treating the targeted disease or condition.

Mahsa Salsabili, PharmD, PhD, addresses the challenges surrounding insurance approval and the limited announcements regarding coverage for prescription digital therapeutics, while exploring various reimbursement models, such as value-based contracts and outcome-based rebates.

Mahsa Salsabili, PharmD, PhD, offers a comprehensive list of factors for healthcare providers and payers to consider in order to streamline the process of prescription digital therapeutics to patients.

Mahsa Salsabili, PharmD, PhD, explores risk and value-based contracting for prescription digital therapeutics, along with strategies for manufacturers to support their utilization and optimization, while also delving into cost-effectiveness modeling and budget impact analysis.

PDTs represent a shift in how treatment is delivered